Results 171 to 180 of about 53,892 (275)

Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of <i>TP53</i> mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.

, 2023
Sylvain Carras, Alexia Torroja, Anouk Emadali, Émilie Montaut, Nicolas Daguindau, Adrian Tempescul, Philippe Moreau, Emmanuelle Tchernonog, Anna Schmitt, Roch Houot, Caroline Dartigeas, Sarah Barbieux, Sélim Corm, Anne Banos, Ludovic Fouillet, Jehan Dupuis, Margaret Macro, Joël Fleury, Fabrice Jardin, Clémentine Sarkozy, G. Damaj, Pierre Feugier, Luc Matthieu Fornecker, Cécile Moluçon‐Chabrot, Véronique Dorvaux, Krimo Bouabdallah, Sandy Amorim, Réda Garidi, Laurent Voillat, Bertrand Joly, Nadine Morineau, Marie Pierre Moles, Hacène Zerazhi, Jean Fontan, Yazid Arkam, Magda Alexis, Vincent Delwail, Jean Pierre Vilque, Loïc Ysebaert, Barbara Burroni, Mary Callanan, Steven Le Gouill, Rémy Gressin   +42 more
openalex   +2 more sources

Mantle cell lymphoma presenting primarily as cutaneous lesions: A case report. [PDF]

World J Clin Cases
Zhou PY, Chen W, Wang L.
europepmc   +1 more source

EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma. [PDF]

Hemasphere
Jerkeman M, Aurer I, Campo E, Cheah CY, Clark J, Doorduijn J, Eyre TA, Fehr M, Giné E, Gomes da Silva M, Klener P, Ladetto M, Ribrag V, Shpilberg O, Walewski J, Dreyling M, EHA Guidelines Committee and the European MCL Network.   +16 more
europepmc   +1 more source

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

, 2016
Arne Kolstad, Lone Bredo Pedersen, Christian Winther Eskelund, Simon Husby, Kirsten Grønbæk, Mats Jerkeman, Anna Laurell, Riikka Räty, Erkki Elonen, Niels Smedegaard Andersen, Peter de Nully Brown, Eva Kimby, Hans Bentzen, Christer Sundström, Mats Ehinger, Marja‐Liisa Karjalainen‐Lindsberg, Jan Delabie, Elisabeth Ralfkiær, Unn‐Merete Fagerli, Herman Nilsson‐Ehle, Grete F. Lauritzsen, Outi Kuittinen, Carsten Utoft Niemann, Christian H. Geisler   +23 more
openalex   +1 more source

Data from Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell Lymphomas

, 2023
Elise A. Chong, Tahamtan Ahmadi, Nicole A. Aqui, Jakub Svoboda, Sunita D. Nasta, Anthony R. Mato, Kristy M. Walsh, Stephen J. Schuster   +7 more
openalex   +1 more source

B-cell receptor signaling and microenvironment crosstalk in mantle cell lymphoma. [PDF]

Cell Commun Signal
Quaglia FM, Gambino S, Galasso M, Vegliante MC, Visco C, Scupoli MT.   +5 more
europepmc   +1 more source

Table S2 from BACH1 Loss Exerts Antitumor Effects on Mantle Cell Lymphoma Cells via Inducing a Tumor-Intrinsic Innate Immune Response and Cell-Cycle Arrest

, 2023
Guilan Li, Min Feng, Ziting Zhang, Jiangyuan Liu, Han Zhang   +4 more
openalex   +1 more source

Identification and functional characterization of splicing factors implicated in mantle cell lymphoma aggressiveness. [PDF]

Sci Rep
Yosudjai J, Poohadsuan J, Samart P, Rodboon N, Issaragrisil S, Luanpitpong S.   +5 more
europepmc   +1 more source

Mantle Cell Lymphoma of Mucosa‐Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study

, 2019
Lucia Morello, Sara Rattotti, Laura Giordano, Mats Jerkeman, Tom van Meerten, Katarzyna Krawczyk, Filipa Moita, Dario Marino, Simone Ferrero, Michał Szymczyk, Igor Aurer, Tarec Christoffer El‐Galaly, Alice Di Rocco, Carlo Visco, Giuseppe Carli, Irene Defrancesco, Carmelo Carlo‐Stella, Martin Dreyling, Armando Santoro, Luca Arcaini   +19 more
openalex   +1 more source

Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real‐world experience [PDF]

, 2019
Young‐Woo Jeon, Seugyun Yoon, Gi June Min, Sung‐Soo Park, Silvia Park, Jae‐Ho Yoon, Sung‐Eun Lee, Byung‐Sik Cho, Ki‐Seong Eom, Yoo‐Jin Kim, Hee‐Je Kim, Seok Lee, Chang‐Ki Min, Jong Wook Lee, Seok‐Goo Cho   +14 more
openalex   +1 more source